Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Argininemia

S E Snyderman, C Sansaricq, W J Chen

    The Journal of Pediatrics
    |April 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Argininemia, a genetic disorder, causes severe neurological issues. Dietary therapy with essential amino acids significantly improved cognitive function and controlled hyperammonemia in affected children.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnosis of metabolic disease.

    Pediatric clinics of North America·2015
    Same author

    Observations on amino acid metabolism in kwashiorkor.

    Journal of tropical pediatrics (London, England : 1955)·2014
    Same author

    The value of plasma citrulline to predict mucosal injury in intestinal allografts.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
    Same author

    Biochemical and molecular diagnosis of lipoamide dehydrogenase deficiency in a North American Ashkenazi Jewish family.

    Journal of inherited metabolic disease·2006
    Same author

    Cerebral glucose metabolism in adults with early treated classic phenylketonuria.

    Molecular genetics and metabolism·2005
    Same author

    Serum citrulline is a potential marker for rejection of intestinal allografts.

    Transplantation proceedings·2002
    Same journal

    Standardized Mean Differences Reveal Substantial Selection Bias in Post-Reduction Management of Intussusception.

    The Journal of pediatrics·2026
    Same journal

    Parenteral Lipid Dose and Bilirubin Neurotoxicity in Extremely Preterm Infants: A Factorial Randomized Trial.

    The Journal of pediatrics·2026
    Same journal

    Refining Oxygen-Carrying Capacity Metrics in Assessing Mortality Risk from Pneumonia in Children.

    The Journal of pediatrics·2026
    Same journal

    Time-to-Transfer and Hospitalization Duration for Severe Congenital Heart Defects: Implications for Perinatal Regionalization.

    The Journal of pediatrics·2026
    Same journal

    Multimodal neuromonitoring in neonatal hypoxic-ischemic encephalopathy and the association with neurodevelopmental outcomes: A Multicenter Study.

    The Journal of pediatrics·2026
    Same journal

    KP.2-Adapted BNT162b2 COVID-19 Vaccine Uptake and Effectiveness in Children.

    The Journal of pediatrics·2026
    See all related articles

    Area of Science:

    • Biochemistry
    • Genetics
    • Neurology

    Background:

    • Argininemia is a rare genetic disorder caused by arginase deficiency.
    • It leads to hyperammonemia and severe neurological symptoms.

    Observation:

    • Two cousins with argininemia presented with hyperactivity, spasticity, ataxia, intellectual disability, and recurrent hyperammonemia.
    • A large family study indicated an autosomal recessive inheritance pattern for arginase deficiency.

    Findings:

    • Treatment with a specialized essential amino acid mixture, with controlled nitrogen intake, effectively managed hyperammonemia.
    • This dietary intervention led to reduced plasma arginine levels and substantial clinical improvement.
    • Affected children demonstrated significant gains in intelligence, moving from intellectual disability towards the normal range.

    Related Experiment Videos

    Implications:

    • Dietary management is a viable therapeutic strategy for argininemia.
    • Early intervention can mitigate severe neurological deficits and improve developmental outcomes.
    • Understanding the genetic basis and metabolic pathways is crucial for developing targeted treatments for urea cycle disorders.